EUVIMEDObjevte EUVIMED
Open access · CC BY-NC 4.0

Pharmacokinetics and Bioavailability of Tolfenamic Acid in Calves: First Evaluation of Subcutaneous Administration

Orhan Corum iD, Pedro Marín, Elena Badillo, Duygu Durna Corum iD, Murat Yuksel iD, Halis Oguz iD, Fátima Martín-Sánchez, Erdinc Turk iD, Elisa Escudero, Devran Coskun iD, Hasan Basri Dingil, Kamil Uney iD

Veterinary Medicine and Science · 2026

DOI: 10.1002/vms3.71024 ↗

At a glance

Journal article in Veterinary Medicine and Science, 2026. Written by Orhan Corum and 11 co-authors. Institution: Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, University of Hatay Mustafa Kemal, Hatay, Türkiye. Major MEDLINE topics: ortho-Aminobenzoates, Anti-Inflammatory Agents, Non-Steroidal. Cited 1 times so far (Crossref); 30 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Coordination of Scientific Research Projects.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Objective

Tolfenamic acid (TA) is a non‐steroidal anti‐inflammatory drug that is commonly used in veterinary medicine. However, information on its pharmacokinetics in calves, particularly following subcutaneous (SC) administration, is limited. The aim of this study was to characterize the disposition of TA in calves following SC, intramuscular (IM) and intravenous (IV) administration.

Methods

Six calves received TA at a dose of 4 mg/kg via each route in a crossover design.

Results

TA exhibited route‐dependent pharmacokinetics. The terminal elimination half‐life increased significantly from IV (6.64 h) to IM (12.79 h) and SC (15.11 h) administration, which is consistent with flip‐flop kinetics following extravascular dosing. Following IV administration, the volume of distribution at steady state was moderate (0.67 L/kg), which suggests extensive plasma protein binding. The time to reach the maximum concentration was similar for the IM and SC routes. However, systemic exposure was markedly lower following SC administration, with peak plasma concentration , area under the curve and bioavailability being approximately half of those observed following IM injection. Plasma concentrations exceeded the EC 50 values required to inhibit prostaglandin E 2 and related inflammatory mediators for up to 24 h after IV administration and up to 48 h after IM or SC administration.

Conclusions

These findings demonstrate that SC administration of TA in calves results in prolonged but reduced systemic exposure compared with IM administration. The results support the need for route‐specific dosing considerations and provide a basis for further studies on residue depletion and determination of withdrawal period in food‐producing calves.

Subjects

MeSH terms (MEDLINE)

ortho-AminobenzoatesAnti-Inflammatory Agents, Non-SteroidalAnimalsCattleInjections, SubcutaneousBiological AvailabilityInjections, IntramuscularHalf-LifeArea Under CurveMaleCross-Over StudiesInjections, Intravenous

Author keywords

NSAIDsbioavailabilitycalvespharmacokineticssubcutaneoustolfenamic acid

Substances

tolfenamic acidortho-AminobenzoatesAnti-Inflammatory Agents, Non-Steroidal

Authors and institutions

  • Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, University of Hatay Mustafa Kemal, Hatay, Türkiye.
  • Department of Pharmacology, University of Murcia, Campus de Espinardo, Murcia, Spain.
  • Department of Obstetrics and Gynecology, Faculty of Veterinary Medicine, University of Hatay Mustafa Kemal, Hatay, Türkiye.
  • Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, University of Selcuk, Konya, Türkiye.
  • Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, University of Siirt, Siirt, Türkiye.
  • Zirve Veterinary Clinic, Iskenderun, Hatay, Türkiye.

ORCID profiles: Orhan Corum, Duygu Durna Corum, Murat Yuksel, Halis Oguz, Erdinc Turk, Devran Coskun, Kamil Uney

Funding

  • Coordination of Scientific Research Projects

Cite

APA

Corum, O., Marín, P., Badillo, E., Durna Corum, D., Yuksel, M., Oguz, H., Martín-Sánchez, F., Turk, E., Escudero, E., Coskun, D., Dingil, H. B., & Uney, K. (2026). Pharmacokinetics and Bioavailability of Tolfenamic Acid in Calves: First Evaluation of Subcutaneous Administration. Veterinary Medicine and Science. https://doi.org/10.1002/vms3.71024

Vancouver

Corum O, Marín P, Badillo E, Durna Corum D, Yuksel M, Oguz H, et al. Pharmacokinetics and Bioavailability of Tolfenamic Acid in Calves: First Evaluation of Subcutaneous Administration. Veterinary Medicine and Science. 2026. doi:10.1002/vms3.71024

BibTeX
@article{Corum2026,
  author = {Corum, Orhan and Marín, Pedro and Badillo, Elena and Durna Corum, Duygu and Yuksel, Murat and Oguz, Halis and Martín-Sánchez, Fátima and Turk, Erdinc and Escudero, Elisa and Coskun, Devran and Dingil, Hasan Basri and Uney, Kamil},
  title = {Pharmacokinetics and Bioavailability of Tolfenamic Acid in Calves: First Evaluation of Subcutaneous Administration},
  journal = {Veterinary Medicine and Science},
  year = {2026},
  doi = {10.1002/vms3.71024}
}
Start for free →